News Releases

Strengthening CAR-T Therapy to Work Against Solid Tumors
Albert Einstein College of Medicine Names Yoon Kang, M.D., Vice Dean for Education
Scott Emmons, Ph.D., Elected to the National Academy of Sciences

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Harris Goldstein

Harris Goldstein, M.D.

Area(s) of expertise: HIV pathogenesis and HIV cure The immune system's antiviral activityEngineering molecules to attack viruses

Dr. Goldstein’s NIH-funded research centers on developing agents to amplify the capacity of the immune system to control HIV infection and achieve a functional cure for the disease. In seeking to “weaponize” the immune system to cure HIV, his lab… Learn more

Einstein in the News


CNN
If Antidepressants Are Killing Your Sex Life, Here's What You Can Do

Jonathan Alpert, M.D., Ph.D., says adjusting antidepressant dosages may help alleviate sexual dysfunction caused by the drugs, but any changes should be done with a physician to avoid withdrawal or the return of mental health symptoms. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.

More coverage on Dr. Alpert

AAMC News
Artistic Medical Students and The Match

Fourth-year Einstein medical student Julia McMillan Castellano, a professional dancer, says physicians' artistic endeavors can serve to remind them of their calling to help patients become healthier and pursue their own passions.

Additional coverage includes MedPage Today and News12

The New York Times
How to Make End-of-Life Planning Less Stressful

Mirnova Ceide, M.D., M.S., discusses the importance of having detailed discussions about end-of-life planning, health care proxies, and living wills for older family members. Dr. Ceide is associate professor of psychiatry and behavioral sciences and of medicine at Einstein, and a psychiatrist at Montefiore.

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos